Explore / Clinical trial
Clinical trial

Single and Repeat Doses of DMT in Healthy Subjects

Algernon PharmaceuticalsActive, not recruitingPhase 1Started Jan 13, 202360 enrolledNetherlandsNCT05559931

Abstract

This study aims to assess the safety and tolerability of single ascending, and fixed repeated doses of N,N-Dimethyltryptamine (DMT) in healthy subjects, when given by intravenous (IV) infusion.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

DMT

Keywords

Stroke

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.